BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 873 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $78,000 | 0.0% | 970 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $78,000 | +30.0% | 970 | +35.5% | 0.01% | +100.0% |
Q1 2021 | $60,000 | -56.5% | 716 | -58.3% | 0.01% | -54.5% |
Q4 2020 | $138,000 | 0.0% | 1,716 | 0.0% | 0.01% | -15.4% |
Q3 2020 | $138,000 | -6.8% | 1,716 | 0.0% | 0.01% | -13.3% |
Q2 2020 | $148,000 | +6.5% | 1,716 | 0.0% | 0.02% | -6.2% |
Q1 2020 | $139,000 | -15.8% | 1,716 | -12.8% | 0.02% | 0.0% |
Q4 2019 | $165,000 | +17.0% | 1,968 | +14.7% | 0.02% | 0.0% |
Q2 2019 | $141,000 | +7.6% | 1,716 | +6.7% | 0.02% | 0.0% |
Q1 2019 | $131,000 | +12.9% | 1,609 | -8.6% | 0.02% | -5.9% |
Q4 2018 | $116,000 | -14.7% | 1,760 | 0.0% | 0.02% | -10.5% |
Q3 2018 | $136,000 | +4.6% | 1,760 | 0.0% | 0.02% | -5.0% |
Q2 2018 | $130,000 | -99.8% | 1,760 | +46.7% | 0.02% | +66.7% |
Q1 2018 | $78,048,000 | +0.6% | 1,200 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $77,568,000 | +6.8% | 1,200 | 0.0% | 0.01% | -14.3% |
Q2 2017 | $72,648,000 | +16.7% | 1,200 | 0.0% | 0.01% | +16.7% |
Q1 2017 | $62,232,000 | +17.0% | 1,200 | 0.0% | 0.01% | +9.1% |
Q4 2016 | $53,208,000 | -6.8% | 1,200 | 0.0% | 0.01% | -8.3% |
Q3 2016 | $57,120,000 | +5.3% | 1,200 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $54,264,000 | +3.6% | 1,200 | 0.0% | 0.01% | -7.7% |
Q1 2016 | $52,356,000 | +111295.7% | 1,200 | -3.6% | 0.01% | +8.3% |
Q4 2015 | $47,000 | -13.0% | 1,245 | -16.8% | 0.01% | -25.0% |
Q3 2015 | $54,000 | – | 1,496 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |